In 2013–2014, the NCI-designated Dan L Duncan Cancer Center at Baylor welcomed top-notch clinicians and scientists to grow and strengthen new and existing programs.
Dr. David Sugarbaker
Dr. David Sugarbaker, a renowned surgeon and leader in lung cancer, esophageal cancer and mesothelioma treatment, joined Baylor as a professor of surgery and the inaugural chief of the new division of general thoracic surgery in the Michael E. DeBakey Department of Surgery.
Sugarbaker serves as director of The Lung Institute at Baylor, a comprehensive, multidisciplinary program focusing on diseases of the lung, including asthma, emphysema, cystic fibrosis, cancer and others.
He joined Baylor in July 2014 from Harvard Medical School and Brigham and Women’s Hospital.
Dr. Steven A. Curley
Dr. Steven A. Curley, chief of the division of surgical oncology and associate director for clinical affairs, joined Baylor to build a multidisciplinary surgical oncology program at the McNair Campus as well as a new collaborative gastroenterology and metabolic surgery group from the divisions of surgical oncology and general surgery.
Curley joined Baylor in October 2013 from The University of Texas MD Anderson Cancer Center where he was professor and Charles B. Barker Chair in surgery, as well as chief of gastrointestinal tumor surgery and medical director of the MD Anderson Gastrointestinal Cancer Multidisciplinary Care Center.
Dr. Matthew Ellis
Dr. Matthew Ellis, an international leader in breast cancer genomics, joined Baylor as director of the Lester and Sue Smith Breast Center at Baylor, a major component of the Duncan Cancer Center that brings together research, patient care and education to expedite the fight against breast cancer.
A world renowned clinician and researcher of the molecular profiling of breast cancer, Ellis joined Baylor in September 2014 from the Washington University School of Medicine in St. Louis to replace Dr. Kent Osborne, who stepped down as director of the Smith Breast Center to focus on his role as director of the Duncan Cancer Center.
Dr. Andrew Sikora
Dr. Andrew Sikora, a clinician-scientist who focuses on head and neck cancer, tumor and cancer immunology and HPV-associated head and neck cancer joined Baylor in August 2014 as vice chair for research and co-director of the newly created head and neck cancer program in the Duncan Cancer Program.
Sikora joined Baylor from the Icahn School of Medicine at Mount Sinai in New York.
Dr. Chenghang (Chuck) Zong
Dr. Chenghang (Chuck) Zong was recruited to Baylor in 2014 as a Scholar of the Cancer Prevention and Research Institute of Texas and as a McNair Scholar, prestigious awards given to rising researchers.
His research focuses on single cell analyses for tumorigenesis and stem cell differentiation.
In October 2014, Zong received a National Institutes of Health Director’s New Innovator Award for cancer genomics.
Dr. Noah Shroyer
Dr. Noah Shroyer, a researcher who focuses on understanding the mechanisms that control intestinal development and homeostasis, and translating this knowledge into novel therapeutic approaches to treat diseases of the intestine such as irritable bowel disease and colorectal cancer.
An alumnus of the Graduate School of Biomedical Sciences at Baylor in molecular and cellular biology and former postdoctoral fellow in molecular and human genetics at Baylor, Shroyer returned to Baylor in 2014 as an associate professor of medicine in the section of gastroenterology and hepatology.
Prior to 2014, Shroyer served on faculty at the Cincinnati Children’s Hospital Medical Center.
Dr. Jacob Mandel
Dr. Jacob Mandel, clinician scientist and neuro-oncologist, joined the Baylor faculty in 2014 as an assistant professor of neurology.
In the clinic, he focuses on primary brain tumors, brain metastasis, leptomeningeal disease and paraneoplastic syndromes. His research focus includes running clinical trials for primary brain tumors and venous thromboembolism in malignant brain tumors.
Dr. Sharmila Anandasabapathy
Dr. Sharmila Anandasabapathy joined Baylor in 2014 as a professor of medicine in the section of gastroenterology and director of Baylor Global Initiatives and the Baylor Global Innovation Center, which seeks to develop novel, environmentally appropriate technologies and approaches to addressing global disease burden.
A member of the Duncan Cancer Center’s Cancer Prevention and Population Sciences Program, her research focus involves the development and validation of novel technologies for diagnosis of early gastrointestinal cancer.